Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free QLGN Stock Alerts

Qualigen Therapeutics (QLGN) SEC Filings & 10K Form

Qualigen Therapeutics logo
$3.46 -0.16 (-4.42%)
Closing price 02/21/2025 03:58 PM Eastern
Extended Trading
$3.52 +0.06 (+1.73%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Qualigen Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/26/2024
3:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
11:15 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
12/10/2024
1:27 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/22/2024
4:28 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/21/2024
4:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K/A
11/14/2024
3:25 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
4:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:55 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
4:06 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
3:35 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:05 PM		Braeden Lichti (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
3:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form DEFA14A
10/09/2024
3:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:10 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:15 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
2:46 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B4
09/05/2024
8:25 AM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
11:15 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
08/22/2024
3:41 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
08/09/2024
5:15 AM		BECHER CAMPBELL (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:28 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
07/25/2024
10:57 AM		PRICE CODY (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:00 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
8:47 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form PRE 14A
07/15/2024
4:06 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:15 AM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
4:25 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
2:35 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:05 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form NT 10-Q
05/03/2024
7:59 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
05/02/2024
11:15 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
04/05/2024
8:59 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
1:35 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form NT 10-K
03/28/2024
3:05 PM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:00 AM		Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:QLGN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored